• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血培养性胆管炎患者初始抗菌治疗不充分对死亡率的影响:一项回顾性队列研究。

Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study.

机构信息

Division of Infectious Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan; Department of Infection Control Science, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital, Tokyo, Japan.

出版信息

Clin Microbiol Infect. 2017 Oct;23(10):740-747. doi: 10.1016/j.cmi.2017.02.027. Epub 2017 Feb 28.

DOI:10.1016/j.cmi.2017.02.027
PMID:28254686
Abstract

OBJECTIVES

Acute cholangitis is a common cause of bacteraemia resulting in severe sepsis or septic shock. The impact of the appropriate initial antimicrobial therapy on short-term mortality in bacteraemic cholangitis has not been well investigated.

METHODS

We conducted a retrospective cohort study of patients with bacteraemic cholangitis at two large tertiary care centres in Tokyo, Japan between 2009 and 2015. We determined the factors associated with 30-day all-cause mortality from the date of drawing the first positive blood culture, using a multivariate logistic regression analysis.

RESULTS

We identified 573 patients with bacteraemic cholangitis (median age, 77 years; male, 58.3%). The 30-day all-cause mortality rate was 6.6% (38/573). Inadequate initial antimicrobial therapy occurred in 133 (23.2%) patients. Factors associated with 30-day all-cause mortality included the Charlson co-morbidity index score >3 (adjusted odds ratio (aOR) 4.12; 95% CI 1.18-14.38), jaundice (total bilirubin >2.5 mg/dL) (aOR 3.39; 95% CI 1.46-7.89), septic shock within 48 h of the first positive blood culture (aOR 3.34; 95% CI 1.42-7.89), biliary obstruction due to hepatobiliary malignancy (aOR 8.00; 95% CI 2.92-21.97), and inadequate initial antimicrobial therapy (aOR 2.78; 95% CI 1.27-6.11).

CONCLUSIONS

Inadequate initial antimicrobial therapy was an important, modifiable determinant of survival.

摘要

目的

急性胆管炎是导致严重脓毒症或感染性休克的常见菌血症病因。适当的初始抗菌治疗对菌血症性胆管炎患者短期死亡率的影响尚未得到充分研究。

方法

我们对 2009 年至 2015 年期间在日本东京的两家大型三级保健中心发生菌血症性胆管炎的患者进行了回顾性队列研究。我们使用多变量逻辑回归分析确定了从首次阳性血培养之日起 30 天内全因死亡率的相关因素。

结果

我们确定了 573 例菌血症性胆管炎患者(中位年龄为 77 岁;男性占 58.3%)。30 天全因死亡率为 6.6%(38/573)。初始抗菌治疗不充分的患者有 133 例(23.2%)。与 30 天全因死亡率相关的因素包括 Charlson 合并症指数评分>3(调整后的优势比[aOR]4.12;95%CI1.18-14.38)、黄疸(总胆红素>2.5mg/dL)(aOR3.39;95%CI1.46-7.89)、首次阳性血培养后 48 小时内发生感染性休克(aOR3.34;95%CI1.42-7.89)、肝胆恶性肿瘤引起的胆道梗阻(aOR8.00;95%CI2.92-21.97)和初始抗菌治疗不充分(aOR2.78;95%CI1.27-6.11)。

结论

初始抗菌治疗不充分是生存的一个重要的、可改变的决定因素。

相似文献

1
Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study.血培养性胆管炎患者初始抗菌治疗不充分对死亡率的影响:一项回顾性队列研究。
Clin Microbiol Infect. 2017 Oct;23(10):740-747. doi: 10.1016/j.cmi.2017.02.027. Epub 2017 Feb 28.
2
Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study.胆管引流成功的急性细菌性胆管炎抗生素治疗时间更短:一项回顾性队列研究。
Clin Microbiol Infect. 2018 Nov;24(11):1184-1189. doi: 10.1016/j.cmi.2018.01.021. Epub 2018 Mar 7.
3
Inadequate empiric antimicrobial therapy and mortality in geriatric patients with bloodstream infection: A target for antimicrobial stewardship.老年血流感染患者经验性抗菌治疗不足与死亡率:抗菌药物管理的一个目标
J Infect Chemother. 2018 Oct;24(10):807-811. doi: 10.1016/j.jiac.2018.06.009. Epub 2018 Jul 20.
4
Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia.革兰阴性杆菌菌血症的急性胆管炎短程抗菌治疗。
Int J Infect Dis. 2017 Feb;55:81-85. doi: 10.1016/j.ijid.2016.12.018. Epub 2016 Dec 24.
5
Characteristics, aetiology, antimicrobial resistance and outcomes of bacteraemic cholangitis in patients with solid tumours: A prospective cohort study.特征、病因、抗菌耐药性和实体瘤患者菌血症性胆管炎的转归:一项前瞻性队列研究。
J Infect. 2017 Feb;74(2):172-178. doi: 10.1016/j.jinf.2016.10.008. Epub 2016 Nov 5.
6
Association of Admission Laboratory Values and the Timing of Endoscopic Retrograde Cholangiopancreatography With Clinical Outcomes in Acute Cholangitis.入院时实验室检查值与内镜逆行胰胆管造影时机与急性胆管炎临床结局的关系。
JAMA Surg. 2016 Nov 1;151(11):1039-1045. doi: 10.1001/jamasurg.2016.2329.
7
Predictors of mortality among bacteremic patients with septic shock receiving appropriate antimicrobial therapy.接受适当抗菌治疗的脓毒性休克菌血症患者的死亡率预测因素。
BMC Anesthesiol. 2014 Mar 25;14:21. doi: 10.1186/1471-2253-14-21.
8
Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment.菌血症性肺炎球菌肺炎患者预后的决定因素:早期充分治疗的重要性。
Scand J Infect Dis. 2010 Mar;42(3):185-92. doi: 10.3109/00365540903418522.
9
Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.脓毒症分类和多重耐药状态对接受适当治疗患者预后的影响。
Crit Care Med. 2015 Aug;43(8):1580-6. doi: 10.1097/CCM.0000000000001013.
10
The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study.初始经验性抗菌治疗不充分对血流感染重症患者死亡率的影响:一项多中心回顾性队列研究
PLoS One. 2016 May 6;11(5):e0154944. doi: 10.1371/journal.pone.0154944. eCollection 2016.

引用本文的文献

1
Optimizing Antimicrobial Use in Japan: Strategies for Dosage, Combination Therapy, De-Escalation, Oral Switching, Duration, and Guideline Adherence.优化日本抗菌药物的使用:剂量、联合治疗、降阶梯治疗、口服转换、疗程及指南依从性策略
Clin Pharmacol. 2025 Aug 4;17:227-233. doi: 10.2147/CPAA.S539674. eCollection 2025.
2
The Presence and Significance of Bacteria and Fungi in Bile Aspirated During ERC-A Retrospective Analysis.经内镜逆行胰胆管造影术(ERC)期间抽取胆汁中细菌和真菌的存在情况及意义——一项回顾性分析
Biomedicines. 2025 May 21;13(5):1255. doi: 10.3390/biomedicines13051255.
3
Risk factors for bile leakage after laparoscopic common bile duct exploration in older patients with choledocholithiasis.
老年胆总管结石患者腹腔镜胆总管探查术后胆漏的危险因素
World J Gastrointest Surg. 2025 Apr 27;17(4):102697. doi: 10.4240/wjgs.v17.i4.102697.
4
Navigating antibiotic therapy in acute cholangitis: Best practices and new insights.急性胆管炎的抗生素治疗策略:最佳实践与新见解
J Hepatobiliary Pancreat Sci. 2025 Jan;32(1):44-57. doi: 10.1002/jhbp.12087. Epub 2024 Nov 13.
5
eHealth and mHealth in Antimicrobial Stewardship to Reduce Mortality in Empirical Antimicrobial Therapy and a Systematic Review with a Meta-Analysis of Adequate Therapy.电子健康和移动健康在抗菌药物管理中的应用,以降低经验性抗菌治疗的死亡率及一项关于充分治疗的系统评价与荟萃分析
Infect Dis Rep. 2024 Aug 1;16(4):707-723. doi: 10.3390/idr16040054.
6
Comparison of antimicrobial therapy termination in febrile and afebrile patients with acute cholangitis after drainage.引流术后发热和不发热的急性胆管炎患者抗菌治疗终止情况的比较。
Sci Rep. 2024 Aug 1;14(1):17858. doi: 10.1038/s41598-024-68999-z.
7
Real-world evidence of systemic treatment practices for biliary tract cancer in Japan: Results of a database study.日本胆道癌系统治疗实践的真实世界证据:数据库研究结果。
J Hepatobiliary Pancreat Sci. 2024 Jul;31(7):468-480. doi: 10.1002/jhbp.1418.
8
Efficacy of Short-Course Antibiotic Therapy for Acute Cholangitis With Positive Blood Cultures: A Retrospective Study.血培养阳性的急性胆管炎短程抗生素治疗的疗效:一项回顾性研究
Cureus. 2024 Apr 24;16(4):e58883. doi: 10.7759/cureus.58883. eCollection 2024 Apr.
9
Impact of inadequate empirical antibiotic treatment on outcome of non-critically ill children with bacterial infections.经验性抗生素治疗不足对非危重症细菌感染患儿结局的影响。
BMC Pediatr. 2024 May 11;24(1):324. doi: 10.1186/s12887-024-04793-0.
10
Antimicrobial therapy outcomes in acute cholangitis: Hilar multiple obstructions single hilar and common bile duct obstructions.急性胆管炎的抗菌治疗结果:肝门部多发梗阻、单一肝门部及胆总管梗阻
JGH Open. 2024 Mar 14;8(3):e13047. doi: 10.1002/jgh3.13047. eCollection 2024 Mar.